نتائج البحث

Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients.

• Authors : Shim YE; Ko Y ...

Subjects: Antilymphocyte Serum* ; Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/methods; Adult

• Source: Scientific reports [Sci Rep] 2023 Aug 02; Vol. 13 (1), pp. 12560. Date of Electronic Publication: 2023 Aug 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients.

• Authors : Ko Y; Department of Surgery, Division of Kidney and Pancreas Transplantation, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Wee YM

Subjects: Antilymphocyte Serum* ; Tacrolimus*; Humans

• Source: PloS one [PLoS One] 2023 Mar 01; Vol. 18 (3), pp. e0280924. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Antithymocyte Globulin Inhibits CD8 + T Cell Effector Functions via the Paracrine Induction of PDL-1 on Monocytes.

• Authors : Copic D; Department of Thoracic Surgery, Laboratory for Cardiac and Thoracic Diagnosis and Regeneration, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Direder M

Subjects: Antilymphocyte Serum*/Antilymphocyte Serum*/Antilymphocyte Serum*/pharmacology ; CD8-Positive T-Lymphocytes*; Humans

• Source: Cells [Cells] 2023 Jan 20; Vol. 12 (3). Date of Electronic Publication: 2023 Jan 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naïve patients with aplastic anemia: an observational retrospective analysis in a single institution.

• Authors : Iino M; Department of Hematology and Hematopoietic Stem Cell Transplantation, Yamanashi Prefectural Central Hospital, Kofu, Japan.; Jinguji A

Subjects: Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Antilymphocyte Serum*/Antilymphocyte Serum*/Antilymphocyte Serum*/therapeutic use; Aged

• Source: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 360-366.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454

تفاصيل العنوان

Outcomes of de novo belatacept-based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization.

• Authors : Patel A; Nephrology, Hackensack University Medical Center, Hackensack, New Jersey, USA.; Shertel T

Subjects: Antilymphocyte Serum*/Antilymphocyte Serum*/Antilymphocyte Serum*/adverse effects ; Calcineurin Inhibitors*/Calcineurin Inhibitors*/Calcineurin Inhibitors*/adverse effects; Abatacept/Abatacept/Abatacept/adverse effects

• Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2022 Nov; Vol. 27 (11), pp. 901-905. Date of Electronic Publication: 2022 Sep 11.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia (REACTS)

• Source: A Non-randomized, Open Label, Multi-center, Phase II Study to Assess the Safety and Efficacy of Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin (r-ATG) and Cyclosporine A (CsA) in

تفاصيل العنوان

BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)

• Source: A Multi-cohort, Randomized, Phase 2, Open-label Study to Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of BIVV020 for Prevention and Treatment of Antibody-mediated Rejection in Adult

تفاصيل العنوان

STOP-T1D Low-Dose (ATG) (TN28)

• Source: Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D

تفاصيل العنوان

Advancing Transplantation Outcomes in Children (ADVANTage)

• Source: Advancing Transplantation Outcomes in Children (CTOT-41)

تفاصيل العنوان

A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia

• Authors : National Cancer Institute (NCI)

• Source: A Pilot Study to Evaluate the Safety and Feasibility of Induction of Mixed Chimerism in Severe Aplastic Anemia Patients With COH-MC-17: A Non-Myeloablative/ Reduced-Intensity, Conditioning Regimen and

تفاصيل العنوان